FDA approves pafolacianine to identify ovarian cancer lesions during surgery - Healio
The FDA approved the imaging drug pafolacianine to help surgeons identify ovarian cancer lesions.Pafolacianine (On Target Laboratories), administered via standard IV prior to surgery, is the first targeted fluorescent imaging agent that illuminates ovarian ca…
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio
The FDA approved the imaging drug pafola… [+3090 chars]
Read More
Other Stories in Health
- Dosa saree, Idli shirt and a pani puri watch? AI turns desi food into fashion
- Where and why men die younger: global data breaks it down
- 8 Best Foldable Rowing Machines, According to Editors and Certified Trainers
- Strawberry Lemon Cream Crepes {Grain-Free Options Included}
- What predicts belief in the afterlife? A massive global study has answers
- Getting active in midlife may boost brain resilience to Alzheimer’s
- May 2025 Cooking Challenge
- May 2025 Cooking Challenge
- TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression
.png)
